Phase I Study of CD19-CAR-T2 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Acute Leukemia
Clinical trial NCT02822326 · UNKNOWN
Trial details
- NCT number
- NCT02822326
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-01
- Primary completion
- 2019-09-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.